Guang Fu
-
- Immune Response and Inflammation 2
- interferon and immune responses 1
-
- Inflammasome and immune disorders 2
- RNA modifications and cancer 2
-
- Cancer Research and Treatments 2
-
- Eicosanoids and Hypertension Pharmacology 2
-
- Gastric Cancer Management and Outcomes 2
-
- Palliative Care and End-of-Life Issues 1
- Co-authors
- Timothy R. BilliarPatricia LoughranMelanie J. ScottMeihong DengPing SunChenxuan YangLei ZhaoZhongjie Yi
- Journals
- SHILAP Revista de lepidopterología (1 paper)Blood (1 paper)Hepatology (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Guang Fu
11 papers receiving 309 citations
Peers
Comparison fields: 5 of 62
- Immunology 132
- Hepatology 30
- Biological Psychiatry 9
- Epidemiology 80
- Molecular Biology 154
Countries citing papers authored by Guang Fu
This map shows the geographic impact of Guang Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guang Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guang Fu more than expected).
Fields of papers citing papers by Guang Fu
This network shows the impact of papers produced by Guang Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guang Fu. The network helps show where Guang Fu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Guang Fu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 1 | |
| 7 | 2021 | 28 | |
| 8 | 2021 | 0 | |
| 9 | 2021 | 28 | |
| 10 | 2020 | 35 | |
| 11 | 2020 | 147 | |
| 12 | 2020 | 3 | |
| 13 | 2020 | 62 | |
| 14 | 2006 | 1 | |
| 15 | [Inhibitory effect against the gastric carcinoma cell growth by the combination of the survivin antisense oligonucleotide and P53 gene]. | 2005 | 0 |
| 16 | 2004 | 1 |
About Guang Fu
Guang Fu is a scholar working on Biochemistry, Biotechnology and Oncology, having authored 16 papers that have together received 309 indexed citations. Recurring topics across this work include Cancer Research and Treatments (2 papers), Eicosanoids and Hypertension Pharmacology (2 papers), Inflammasome and immune disorders (2 papers), RNA modifications and cancer (2 papers), Immune Response and Inflammation (2 papers), Gastric Cancer Management and Outcomes (2 papers), Palliative Care and End-of-Life Issues (1 paper) and interferon and immune responses (1 paper). The work is most often cited by research in Immunology (132 citations), Hepatology (30 citations) and Biological Psychiatry (9 citations). Guang Fu has collaborated with scholars based in China and United States. Frequent co-authors include Timothy R. Billiar, Patricia Loughran, Melanie J. Scott, Meihong Deng, Ping Sun, Chenxuan Yang, Lei Zhao, Zhongjie Yi, Wenbo Li and Shilai Li. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.